132 related items for PubMed ID: 6574528
1. DST in depression is unaffected by altering the clock time of its administration.
Pepper GM, Davis KL, Davis BM, Krieger DT.
Psychiatry Res; 1983 Feb; 8(2):105-9. PubMed ID: 6574528
[Abstract] [Full Text] [Related]
2. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
[Abstract] [Full Text] [Related]
3. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls.
Thompson LM, Rubin RT, McCracken JT.
Psychoneuroendocrinology; 1992 Oct; 17(5):507-15. PubMed ID: 1484917
[Abstract] [Full Text] [Related]
4. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
Pfohl B, Sherman B, Schlechte J, Stone R.
Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
[Abstract] [Full Text] [Related]
5. Acute administration of buspirone increases the escape of hypothalamic-pituitary-adrenal-axis hormones from suppression by dexamethasone in depression.
Maes M, Van Gastel A, Meltzer HY, Cosyns P, Blockx P, Desnyder R.
Psychoneuroendocrinology; 1996 Jan; 21(1):67-81. PubMed ID: 8778905
[Abstract] [Full Text] [Related]
6. The relationships between the cortisol responses to dexamethasone and to L-5-HTP, and the availability of L-tryptophan in depressed females.
Maes M, Vandewoude M, Schotte C, Maes L, Martin M, Scharpe S, Blockx P.
Biol Psychiatry; 1990 Mar 15; 27(6):601-8. PubMed ID: 2322619
[Abstract] [Full Text] [Related]
7. Are the thyroid and adrenal system alterations linked in depression?
Mokrani MC, Duval F, Erb A, Gonzalez Lopera F, Danila V.
Psychoneuroendocrinology; 2020 Dec 15; 122():104831. PubMed ID: 33068950
[Abstract] [Full Text] [Related]
8. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
[Abstract] [Full Text] [Related]
9. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL.
Arch Gen Psychiatry; 1987 Apr 15; 44(4):328-36. PubMed ID: 3566455
[Abstract] [Full Text] [Related]
10. Dexamethasone suppression test in diagnosis of depressive illness.
Hayes PE, Ettigi P.
Clin Pharm; 1983 Apr 15; 2(6):538-45. PubMed ID: 6140096
[Abstract] [Full Text] [Related]
11. A multivariate study of simultaneous escape from suppression by dexamethasone of urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and beta-endorphin in melancholic patients.
Maes M, Vandervorst C, Suy E, Minner B, Raus J.
Acta Psychiatr Scand; 1991 Jun 15; 83(6):480-91. PubMed ID: 1652880
[Abstract] [Full Text] [Related]
12. Enhanced adrenal sensitivity to exogenous cosyntropin (ACTH alpha 1-24) stimulation in major depression. Relationship to dexamethasone suppression test results.
Jaeckle RS, Kathol RG, Lopez JF, Meller WH, Krummel SJ.
Arch Gen Psychiatry; 1987 Mar 15; 44(3):233-40. PubMed ID: 3030218
[Abstract] [Full Text] [Related]
13. The dexamethasone suppression and metyrapone tests in depression.
Morphy MA, Fava GA, Perini GI, Molnar G, Zielezny M, Lisansky J.
Psychiatry Res; 1985 Jun 15; 15(2):153-8. PubMed ID: 3862146
[Abstract] [Full Text] [Related]
14. Dexamethasone suppression test response in major depression: stability across hospitalizations.
Coryell W, Schlesser MA.
Psychiatry Res; 1983 Mar 15; 8(3):179-89. PubMed ID: 6574537
[Abstract] [Full Text] [Related]
15. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Müller-Oerlinghausen B, Bauer M.
Depress Anxiety; 2003 Mar 15; 17(1):43-8. PubMed ID: 12577277
[Abstract] [Full Text] [Related]
16. Age effects in serial hypothalamic-pituitary-adrenal monitoring.
Greden JF, Flegel P, Haskett R, Dilsaver S, Carroll BJ, Grunhaus L, Genero N.
Psychoneuroendocrinology; 1986 Mar 15; 11(2):195-204. PubMed ID: 3749402
[Abstract] [Full Text] [Related]
17. HPA axis dysregulation in men with hypersexual disorder.
Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J.
Psychoneuroendocrinology; 2016 Jan 15; 63():247-53. PubMed ID: 26519779
[Abstract] [Full Text] [Related]
18. A revised interpretation of postdexamethasone ACTH and cortisol findings in unipolar depressed females.
Maes M, Vandewoude M, Schotte C, Maes L, Martin M, Blockx P.
Psychiatry Res; 1990 Nov 15; 34(2):107-26. PubMed ID: 1962860
[Abstract] [Full Text] [Related]
19. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
Sher L.
ScientificWorldJournal; 2006 Oct 31; 6():1398-404. PubMed ID: 17086345
[Abstract] [Full Text] [Related]
20. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
Hudson JI, Pope HG, Jonas JM, Laffer PS, Hudson MS, Melby JC.
Psychiatry Res; 1983 Feb 31; 8(2):111-7. PubMed ID: 6574529
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
